Conference Report: The 1st Conference in Asia-Pacific on Recent Issues in Bioanalysis

Bioanalysis

Volumn 3, Issue 7, 2011, Pages 723-731

  Dumont, Isabelle ^a   Garofolo, Fabio ^a  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BIOLOGICAL PRODUCT;

ANALYSIS; ASIA; BIOANALYSIS; CANADA; CONFERENCE PAPER; DRUG ANALYSIS; DRUG DEVELOPMENT; DRUG INDUSTRY; MOLECULAR WEIGHT; QUALITY CONTROL; SCIENTIST; CHEMICAL ANALYSIS; HUMAN; METHODOLOGY; PHARMACEUTICS;

BIOLOGICAL PRODUCTS; BIOPHARMACEUTICS; CHEMISTRY TECHNIQUES, ANALYTICAL; HUMANS;

EID: 79953672878     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.11.47     Document Type: Conference Paper

References (16)

1. Garofolo W, Lam H, Garofolo F. Spotlight on the Calibration and Validation Group. Bioana lysis 1(3), 517-519 (2009).
2. Savoie N, Booth BP, Bradley T et al. 2008 White Paper: The 2nd Calibration and Validation Group Workshop on Recent Issues in Good Laboratory Practice Bioana lysis. Bioana lysis 1(1), 19-30 (2009).
3. Savoie N, Garofolo F, van Amsterdam P et al. 2009 White Paper on Recent Issues in Regulated Bioana lysis from the 3rd Calibration and Validation Group Workshop. Bioana lysis 2(1), 53-68 (2010).
4. Savoie N, Garofolo F, van Amsterdam P et al. 2010 White Paper on Recent Issues in Regulated Bioana lysis & Global Harmonization of Bioanalytical Guidance. Bioana lysis 2(12), 1945-1960 (2010).
5. Timmerman P, Lowes S, Fast DM et al. Request for global harmonization of the guidance for bioanalytical method validation and sample ana lysis. Bioana lysis 2(4), 683 (2010).
6. Bansal S, Arnold M, Garofolo F. International harmonization of bioanalytical guidance. Bioana lysis 2(4), 685-687 (2010).
7. van Amsterdam P, Lausecker B, Luedtke S et al. Towards harmonized regulations for bioana lysis: moving forward! Bioana lysis 2(4), 689-690 (2010).
8. van Amsterdam P, Arnold M, Bansal S et al. Building the global bioana lysis consortium: working towards a functional globally acceptable and harmonized guideline on bioanalytical method validation. Bioana lysis 2(11), 1801-1803 (2010).
9. Premkumar N, Lowes S, Jersey J et al. Formation of a global contract research organization council for bioana lysis. Bioana lysis 2(11), 1797-1800 (2010).
10. Viswanathan CT, Bansal S, Booth B et al. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. AAPS J. 9(1), E30-E42 (2007). (Pubitemid 46296546)
11. US FDA. Guidance for Industry: Bioanalytical Method Validation. US Department of Health and Human Services, US FDA, Center for Drug Evaluation and Research, Rockville, MD, USA (2001).
12. EMA. Draft Guideline on the Validation of Bioanalytical Methods. EMA, Committee for Proprietary Medicinal Products (CPMP), London, UK (2009).
13. US FDA. Guidance for Industry: Safety Testing for Drug Metabolites. US Department of Health and Human Services, US FDA, Center for Drug Evaluation and Research, Rockville, MD, USA (2008)
14. ICH-M3(R2) Guidance on Non-Clinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals (Current Step 4 version). International Conference of Harmonisation of technical requirements for registration of pharmaceuticals for human use. (2009).
15. Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China (2010) Vol. II, Appendix XIX B. China Medical Science and Technology Press, Beijing, China (2010).
16. Tang D, Zhong DF. Regulated bioana lysis and the desire for harmonized regulations in China. Bioana lysis 2(12), 1913-1919 (2010).